ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,789.73
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) News

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZIVO
DateTimeSourceHeadlineSymbolCompany
26/04/202418:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202413:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202413:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
09/04/202416:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
14/03/202413:16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/02/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
15/02/202413:54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/02/202421:54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
29/01/202413:00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
22/01/202422:15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
17/01/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
05/01/202422:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
04/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
03/01/202422:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
02/01/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
27/11/202314:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
22/11/202321:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
13/11/202321:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
03/11/202314:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202317:20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202312:30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202313:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
26/10/202313:30Business WireZIVO Bioscience Announces Reverse Stock SplitNASDAQ:ZIVOZivo Bioscience Inc
04/10/202322:08Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ZIVOZivo Bioscience Inc
03/10/202313:30GlobeNewswire Inc.ZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
21/09/202314:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
19/09/202321:15Business WireTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
16/08/202320:00Business WireZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsNASDAQ:ZIVOZivo Bioscience Inc
14/08/202321:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
09/08/202321:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:ZIVO

Your Recent History

COIN
BITMUSD
LSE
0IQC
Fluor
COIN
XMCCBTC
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved